Short Communication - (2025) Volume 14, Issue 6
Received: 01-Dec-2025, Manuscript No. jhoa-26-187877;
Editor assigned: 03-Dec-2025, Pre QC No. P-187877;
Reviewed: 17-Dec-2025, QC No. Q-187877;
Revised: 22-Dec-2025, Manuscript No. R-187877;
Published:
29-Dec-2025
, DOI: 10.37421/2167-1095.2025.14.550
Citation: Petrov, Pavel. ”Hypertension: Threat to Cardiovascular and Kidney Health.” J Hypertens 14 (2025):550.
Copyright: © 2025 Petrov P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited
Hypertension significantly elevates the risk of several cardiovascular complications, including myocardial infarction, stroke, heart failure, and chronic kidney disease. These complications arise from the sustained elevated pressure damaging blood vessels, leading to atherosclerosis, endothelial dysfunction, and left ventricular hypertrophy. Effective blood pressure management is crucial for mitigating these adverse outcomes [1].
The impact of resistant hypertension on cardiovascular outcomes is substantial. Patients with resistant hypertension, defined as blood pressure remaining above goal despite the use of three or more antihypertensive medications (including a diuretic) or controlled on four or more medications, experience a higher incidence of cardiovascular events and mortality. Understanding and managing this challenging subgroup is vital [2].
Endothelial dysfunction is a key mechanism linking hypertension to cardiovascular complications. Elevated blood pressure impairs the ability of the endothelium to produce nitric oxide, a crucial vasodilator and anti-atherosclerotic molecule. This dysfunction contributes to vascular stiffness, inflammation, and the development of atherosclerotic plaques [3].
Left ventricular hypertrophy (LVH) is a common consequence of chronic hypertension, reflecting the heart's adaptive response to increased afterload. While initially compensatory, LVH eventually leads to diastolic and systolic dysfunction, increasing the risk of heart failure, arrhythmias, and sudden cardiac death [4].
Hypertension is a major risk factor for ischemic stroke. High blood pressure accelerates atherosclerosis in cerebral arteries and increases the likelihood of plaque rupture or embolism, leading to reduced blood flow and neuronal damage. Aggressive blood pressure control is a cornerstone of stroke prevention [5].
The relationship between hypertension and heart failure is bidirectional and complex. Hypertension is a leading cause of heart failure with preserved ejection fraction (HFpEF) and contributes to the development of heart failure with reduced ejection fraction (HFrEF) through various mechanisms including LVH and ischemic heart disease [6].
Chronic kidney disease (CKD) is both a consequence and a contributor to hypertension. Sustained high blood pressure damages the small blood vessels in the kidneys, impairing their function. Conversely, impaired kidney function can lead to fluid retention and activation of the renin-angiotensin-aldosterone system, further elevating blood pressure [7].
Hypertension is a significant risk factor for coronary artery disease (CAD), including myocardial infarction. High blood pressure promotes endothelial dysfunction, lipid deposition, and plaque formation in the coronary arteries, leading to reduced blood flow and potential arterial occlusion [8].
The advent of ambulatory blood pressure monitoring (ABPM) has refined our understanding of hypertension's cardiovascular impact. Nocturnal dipping patterns and masked hypertension, identified through ABPM, are independently associated with increased cardiovascular risk, highlighting the importance of out-of-office BP measurements [9].
Hypertension disproportionately affects certain populations, and understanding these disparities is critical for equitable cardiovascular care. Factors such as genetics, socioeconomic status, and access to healthcare contribute to higher hypertension prevalence and worse cardiovascular outcomes in specific ethnic and racial groups [10].
Hypertension significantly elevates the risk of several cardiovascular complications, including myocardial infarction, stroke, heart failure, and chronic kidney disease. These complications arise from the sustained elevated pressure damaging blood vessels, leading to atherosclerosis, endothelial dysfunction, and left ventricular hypertrophy. Effective blood pressure management is crucial for mitigating these adverse outcomes [1].
The impact of resistant hypertension on cardiovascular outcomes is substantial. Patients with resistant hypertension, defined as blood pressure remaining above goal despite the use of three or more antihypertensive medications (including a diuretic) or controlled on four or more medications, experience a higher incidence of cardiovascular events and mortality. Understanding and managing this challenging subgroup is vital [2].
Endothelial dysfunction is a key mechanism linking hypertension to cardiovascular complications. Elevated blood pressure impairs the ability of the endothelium to produce nitric oxide, a crucial vasodilator and anti-atherosclerotic molecule. This dysfunction contributes to vascular stiffness, inflammation, and the development of atherosclerotic plaques [3].
Left ventricular hypertrophy (LVH) is a common consequence of chronic hypertension, reflecting the heart's adaptive response to increased afterload. While initially compensatory, LVH eventually leads to diastolic and systolic dysfunction, increasing the risk of heart failure, arrhythmias, and sudden cardiac death [4].
Hypertension is a major risk factor for ischemic stroke. High blood pressure accelerates atherosclerosis in cerebral arteries and increases the likelihood of plaque rupture or embolism, leading to reduced blood flow and neuronal damage. Aggressive blood pressure control is a cornerstone of stroke prevention [5].
The relationship between hypertension and heart failure is bidirectional and complex. Hypertension is a leading cause of heart failure with preserved ejection fraction (HFpEF) and contributes to the development of heart failure with reduced ejection fraction (HFrEF) through various mechanisms including LVH and ischemic heart disease [6].
Chronic kidney disease (CKD) is both a consequence and a contributor to hypertension. Sustained high blood pressure damages the small blood vessels in the kidneys, impairing their function. Conversely, impaired kidney function can lead to fluid retention and activation of the renin-angiotensin-aldosterone system, further elevating blood pressure [7].
Hypertension is a significant risk factor for coronary artery disease (CAD), including myocardial infarction. High blood pressure promotes endothelial dysfunction, lipid deposition, and plaque formation in the coronary arteries, leading to reduced blood flow and potential arterial occlusion [8].
The advent of ambulatory blood pressure monitoring (ABPM) has refined our understanding of hypertension's cardiovascular impact. Nocturnal dipping patterns and masked hypertension, identified through ABPM, are independently associated with increased cardiovascular risk, highlighting the importance of out-of-office BP measurements [9].
Hypertension disproportionately affects certain populations, and understanding these disparities is critical for equitable cardiovascular care. Factors such as genetics, socioeconomic status, and access to healthcare contribute to higher hypertension prevalence and worse cardiovascular outcomes in specific ethnic and racial groups [10].
Hypertension poses a significant threat to cardiovascular health, increasing the risk of myocardial infarction, stroke, heart failure, and chronic kidney disease. These complications stem from sustained high blood pressure damaging blood vessels, leading to atherosclerosis and endothelial dysfunction. Resistant hypertension, characterized by uncontrolled blood pressure despite multiple medications, is associated with a higher incidence of cardiovascular events and mortality. Endothelial dysfunction, a key mechanism, impairs nitric oxide production, contributing to vascular stiffness and inflammation. Left ventricular hypertrophy, an adaptive response to increased afterload, can progress to heart failure. Hypertension is a major driver of ischemic stroke and heart failure, and it has a complex, bidirectional relationship with chronic kidney disease. Ambulatory blood pressure monitoring offers a more nuanced understanding of hypertension's impact, identifying risks associated with nocturnal dipping patterns and masked hypertension. Furthermore, hypertension disparities exist across different populations, influenced by genetics, socioeconomic status, and healthcare access, necessitating equitable care strategies.
None
None
Journal of Hypertension: Open Access received 614 citations as per Google Scholar report
